Share
644 Posts.
lightbulb Created with Sketch. 66
clock Created with Sketch.
11/08/17
00:09
Share
Originally posted by beefarmer
↑
Bigsky, this was my second float this year and both have performed poorly. However saying that I would not have sold even if they performed like AL8.
I am a long termer, hence my serious like of CYC. In fact, CYC is my super stock but I wont bore you.
No one gives a cracker about the backroom fandangos if a miffed crowd are flogging the stock. Hopefully people can separate the wheat from the chaff and this little company has what it takes. For freddys sake, there is a nobel prize behind all this chemistry.
For those with cohunas, what better way than to top up at 15c, and make one third when she hits 20.
Make no mistake, she will hit 20. Again. Look at the other diagnostic testing that can be done here with other types of cancers. All it needs, like a lot of stocks, is that huge break and off we go.
Expand
My view is sales and licensing to expand US market 2017 and move into Europe 2017/18. R&D to commercialise other cancer diagnostics through 2020. Upside $100M market cap 2020 and happy days. I am holding and here for the ride. DYOR